>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead
AGGRASTAT (tirofiban HCl).
July 11, 2014
Medicure Announces Shares for Debt Settlement Read more
July 7, 2014
Medicure Announces Grant of Options Read more
July 3, 2014
Medicure Acquires Minority Position In Pharmaceutical Manufacturer, Apicore Read more
Sign up to receive email updates such as Press Release nofications and other company news.